Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies
Titel:
Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies
Auteur:
Röth, Alexander Rottinghaus, Scott T. Hill, Anita Bachman, Eric S. Kim, Jin Seok Schrezenmeier, Hubert Terriou, Louis Urbano-Ispizua, Álvaro Wells, Richard A. Jang, Jun Ho Kulasekararaj, Austin G. Szer, Jeff Aguzzi, Rasha Damokosh, Andrew I. Shafner, Lori Lee, Jong Wook